Subvolts take AI accelerates longevity research and drug discovery, potentially reversing aging. Apr 28, 2026 - Business
- Learn how AI is accelerating drug discovery and healthspan research, offering new avenues for investment and innovation.
- Everyday users
- Understand how AI might help you live a longer, healthier life and explore new treatments for aging and disease.
Features a leading genetics professor discussing AI's role in healthspan and longevity research.
David Sinclair: The GLP-1 Side Effect No One Talks About, What AI Found in His Lab, and Reversing Blindness | Q&A EP #251
Audio streams from PHD Ventures. Your place is remembered on this device.
From Subvolts
Summary and analysis by Subvolts editorial, AI-assisted.
Peter Diamandis interviews David Sinclair on Moonshots about AI's role in accelerating drug discovery and biological age reversal. They discuss longevity, GLP-1s, genetics, and the future of healthspan. The episode, filmed at the Abundance360 Summit, explores how AI can speed up research and improve human health.
This episode talks about how smart computers (AI) are helping scientists find new medicines faster. They are also looking into ways to make people live healthier for longer, possibly even reversing the aging process.
This episode offers insights into how AI is directly impacting biological research and healthspan extension. Listeners will learn about cutting-edge longevity science and its potential acceleration through AI. It is for anyone interested in the future of health, biotech, and the intersection of AI with medicine. This connects to frontier labs' current focus on AI for scientific discovery and drug development.
- HostPeter Diamandis
- GuestDavid SinclairProfessor of Genetics, Harvard Medical School
- Guest: David Sinclair
- Show: Moonshots with Peter Diamandis
- Episode Length: 27 minutes
- Filming Location: 2026 Abundance360 Summit
This episode was filmed at the 2026 Abundance360 Summit. Learn more at https://www.abundance360.com/
This Q&A is about longevity, and especially how David Sinclair sees AI speeding up drug discovery, biological-age reversal, and the future of healthspan. It also covers GLP-1s, telomeres, genetics, muscle preservation, hormone replacement, indoor environment, and the role of mindset in aging well.
Get access to metatrends 10+ years before anyone else - https://qr.diamandis.com/metatrends
Peter H. Diamandis, MD, is the Founder of XPRIZE, Singularity University, ZeroG, and A360
David A. Sinclair, A.O., Ph.D., is a tenured Professor of Genetics at Harvard Medical School and a serial biotech entrepreneur. Peter H. Diamandis, MD, is the Founder of XPRIZE, Singularity University, ZeroG, and A360
–
My companies:
Apply to Dave's and my new fund:https://qr.diamandis.com/linkventureslanding
Go to Blitzy to book a free demo and start building today: https://qr.diamandis.com/blitzy
Your body is incredibly good at hiding disease. Schedule a call with Fountain Life to add healthy decades to your life, and to learn more about their Memberships: https://www.fountainlife.com/peter
_
Connect with Peter:
Connect with David
Listen to MOONSHOTS:
–
*Recorded on March 9th, 2026
*The views expressed by me and all guests are personal opinions and do not constitute Financial, Medical, or Legal advice.
Learn more about your ad choices. Visit megaphone.fm/adchoices
1 h 46Flying Tesla Car, Robot Brains Halving in Cost Every 3 Weeks, and Why Incentives Decide AI Alignment | #303
WithAnousheh Ansari, Salim Ismail, Emad Mostaque
2 h 47Same guests, other shows
33 minQuestions people ask
- What is the main topic of the Q&A?
- The Q&A focuses on longevity, how AI speeds up drug discovery and biological age reversal, and the future of healthspan.
- Where was this episode filmed?
- This episode was filmed at the 2026 Abundance360 Summit.
Page generated Oct 19, 2026. Summaries are Subvolts' own; the audio, artwork and notes belong to PHD Ventures.